Richard Zollner
Pfizer (United States)(US)
Publications by Year
Research Areas
Monoclonal and Polyclonal Antibodies Research, T-cell and B-cell Immunology, Osteoarthritis Treatment and Mechanisms, Antimicrobial Resistance in Staphylococcus, Immune Response and Inflammation
Most-Cited Works
- → Cutting Edge: Identification of GL50, a Novel B7-Like Protein That Functionally Binds to ICOS Receptor(2000)230 cited
- → Prevention of cartilage degeneration in a rat model of osteoarthritis by intraarticular treatment with recombinant lubricin(2009)227 cited
- → Binding and localization of recombinant lubricin to articular cartilage surfaces(2006)154 cited
- → Crystal structures of the two major aggrecan degrading enzymes, ADAMTS4 and ADAMTS5(2007)139 cited
- → B7.1 Is a Quantitatively Stronger Costimulus Than B7.2 in the Activation of Naive CD8+ TCR-Transgenic T Cells(1998)71 cited
- → Staphylococcal Enterotoxin B–Specific Monoclonal Antibody 20B1 Successfully Treats Diverse Staphylococcus aureus Infections(2013)54 cited
- Potent activity of soluble B7-IgG fusion proteins in therapy of established tumors and as vaccine adjuvant.(1999)
- → Characterization of murine Flt4 ligand/VEGF-C(1997)44 cited
- → Transient CHO expression platform for robust antibody production and its enhanced N‐glycan sialylation on therapeutic glycoproteins(2018)44 cited
- → Humanized Staphylococcal Enterotoxin B (SEB)–Specific Monoclonal Antibodies Protect From SEB Intoxication and Staphylococcus aureus Infections Alone or as Adjunctive Therapy With Vancomycin(2014)36 cited